5678-46-6

Usage

Uses

Used in Pharmaceutical Applications:
3-Amino-3-(2-hydroxyphenyl)propionic acid is used as a pharmaceutical intermediate for the synthesis of various drugs and therapeutic agents. Its unique chemical structure allows it to be a key component in the development of new medications.
Used in Research Applications:
In the field of scientific research, 3-Amino-3-(2-hydroxyphenyl)propionic acid is used as a research compound to study its potential role in the treatment of diseases like phenylketonuria. It helps researchers understand its mechanism of action and explore its therapeutic potential.
Used in Neurotransmitter and Hormone Synthesis:
3-Amino-3-(2-hydroxyphenyl)propionic acid is used as a precursor in the biosynthesis of neurotransmitters and hormones, playing a vital role in maintaining the proper functioning of the nervous and endocrine systems.
Used in Food Industry:
In the food industry, 3-Amino-3-(2-hydroxyphenyl)propionic acid is used as a natural source of the amino acid, which can be incorporated into various food products to enhance their nutritional value and support health benefits.
Used in Cosmetics Industry:
3-Amino-3-(2-hydroxyphenyl)propionic acid may be used in the cosmetics industry as an active ingredient in skincare and beauty products, potentially offering benefits such as antioxidant properties and supporting skin health.

InChI:InChI=1/C9H11NO3/c10-7(5-9(12)13)6-3-1-2-4-8(6)11/h1-4,7,11H,5,10H2,(H,12,13)

Upstream product

• 91-64-5 coumarin 
• 141-82-2 malonic acid 
• 90-02-8 salicylaldehyde 
• 67-56-1 methanol 
• 7803-49-8 hydroxylamine 
• 614-60-8 o-Coumaric acid 
• 64-17-5 ethanol 
• 859951-60-3 β-hydroxylamino-hydro-o-coumarohydroxamic acid oxime hydrate 
• 3943-94-0 (E)-ethyl 2-hydroxycinnamate 

Relevant academic research and scientific papers

Synthesis, hypoglycemic effect, antimicrobial and molecular docking studies of organotin(IV) complexes derived from N -phthalimido β-amino acid derivatives

N-Phthalimido β-amino acid derivatives, 3-phthalimido-3(2-hydroxyphenyl) propanoic acid (P2HPA) and 3-phthalimido-3(2-nitrophenyl) propanoic acid (P2NPA) with new series of diand triorganotin(IV) complexes (1-12) have been designed and synthesized. All the ligands and organotin(IV) complexes were characterized by elemental analysis, Fourier transform infrared spectroscopy (FTIR), nuclear magnetic resonance (1H, 13C, 119Sn) spectroscopy and electron ionization mass spectrometry (EI-MS). Synthesized ligands and complexes were screened to determine the antibacterial activity and results showed that the triorganotin(IV) complexes have better activity compared to diorganotin(IV) complexes and ligands. In addition, molecular docking analysis of ligands on the catalytic pocket of sortase A (PDB ID 1T2W) showed that the ligands can bind the active amino acid residues in the pocket. The antioxidant activity was also performed by the DPPH (1,1-diphenyl-2-picrylhydrazyl radical) method and complexes showed better results than ligands. The compounds were also tested in vivo to determine the hypoglycemic activities on different groups of alloxan induced diabetic rabbits. The complexes (1-6) were found better hypoglycemic agents as they stabilized the glucose level to about 175-105 mg dL-1 as compared to ligand P2HPA.

2-HYDROXYPHENYLALKYLAMINE DERIVATIVES AND MAILLARD REACTION INHIBITORS

The present invention relates to a 2-hydroxyphenyl alkylamine derivative represented by the general formula: wherein R1, R2, R3and R4are the same or different: and each represents a hydrogen atom, a lower alkyl